Issued patent recognizes CIRCULOGENE’s novel method of enriching cfDNA without DNA isolation, extraction or purification, enabling “in situ” genetic manipulation of biofluid samples. BIRMINGHAM, Ala. – CIRCULOGENE, an innovative molecular diagnostics company transforming precision medicine [...]
73-Year-Old PatientATM, INCREASING ctDNA MUTATIONS “Using plasma NGS in monitoring treatment response in pancreatic - and all - cancers can be notably impactful in helping patients live longer and live better. Plasma ctDNA can identify [...]
56-Year-Old MaleBRCA SOMATIC RESULTS “This case brings up two treatment decisions. What chemotherapy and what, if any, maintenance therapy?” - Dr. Paul Walker, Chief Medical Officer, Former Director of Thoracic Oncology at East Carolina University [...]
46-Year-Old FemaleATM GERMLINE AND ALK FUSION SOMATIC RESULTS “The germline ATM and somatic ALK fusion molecular findings in this individual with pancreatic cancer have a tremendous impact on not only her treatment but also her [...]
CIRCULOGENE Free Webinar Drawing NGS Plasma at Time of Lung Biopsy, To Do or Not To Do Jun 3, 2020 7:00PM Eastern Time Please join us for this free educational webinar where our panel [...]
Cell-Free DNA Concentration Associated with Injury Severity and Survival in ICU Animal Study using CIRCULOGENE’s Proprietary Liquid Biopsy Technology cfDNA levels correlate significantly with biomarkers of multiorgan damage in first abstract stemming from DOD research grant to [...]
Dear All – I want to start this by saying Thank You! to all of our clients and staff members. Each day – with your efforts – you help hundreds of patients by giving them [...]
Current Trends in Clinical & Medical Sciences Chen Hsiung Yeh* Circulogene Theranostics, Birmingham, USA Received Date: January 24, 2020 Published Date: January 29, 2020 Biological Fragmentation of Circulating Cell-free DNA Alters Genetic Representation Click here to [...]
$1.5 Million grant to The Geneva Foundation will use CIRCULOGENE’s liquid biopsy to quickly ID and accurately quantify organ-specific injury markers for improved treatment and survival in severely wounded military and civilian personnel. BIRMINGHAM, Ala.--(BUSINESS [...]
Posters present data on utility of cfDNA for patient mutation load in NSCLC; cfRNA PD-L1 + MSI single-blood-tube testing; and innovative salvage of buccal NGS testing BIRMINGHAM, Ala.--(BUSINESS WIRE)-- CIRCULOGENE, advancing precision medicine through personalized [...]